Announcement marks fourth consecutive year Vitae has made the list
FORT WASHINGTON, PA – October 29, 2013 – Vitae Pharmaceuticals, Inc., a clinical-stage
biopharmaceutical company discovering and developing novel, small molecule, best-in-class
compounds, today announced it was named one of Central Penn Business Journal’s 100 Best
Places to Work in PA for 2013. The company will be honored at a reception on Thursday, Dec.
5, at the Lancaster County Convention ...
One of the best things about having time to sit down with a company's
executive team and discuss matters such as pipeline and business strategy at
leisure is the chance to intersperse more philosophical questions that address
how a company views itself and the work environment it tries to
In meeting a few weeks ago with the executive team at Vitae
Pharmaceuticals near Philadelphia for a
profile in "The Pink Sheet," I got more information than I could process on
Vitae ranked second overall in life sciences industry; highest-ranked U.S. company
Survey measured responses of more than 200 companies worldwide
Fort Washington, PA, June 12, 2013 – Vitae Pharmaceuticals, Inc., a clinical‐stage
biopharmaceutical company discovering and developing novel, small molecule, best‐in‐class
compounds, today announced that the company ranked second among life sciences companies
in the 11th annual Best Places to Work in Industry survey conducted by The Scient...
Robust efficacy results achieved in multiple sclerosis mouse model with record-breaking
Vitae’s time from initiation of program to animal proof-of-principle with qualified lead has
consistently been less than 18 months
FORT WASHINGTON, PA – June 4, 2013 – Vitae Pharmaceuticals, Inc., a clinical-stage
biopharmaceutical company discovering and developing novel, small molecule, first- and bestin-class compounds, today announced that it has achieved animal proof-of-principle of ...